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A 32-residue peptide has been isolated from extracts of porcine upper intestine. Amino acid sequence 
determination showed that the peptide is a fragment of hemoglobin, corresponding to the C-terminal part 
of the P-chain. The region in the &chain which precedes the isolated fragment is hydrophobic (8 
Leu/Val/Ile) and has no charges at 10 preceding positions. It therefore, to some extent, resembles the 
structure of ‘signal sequences’ which may suggest a specific cleavage site in hemoglobin P-chains. 
Hemoglobin P-chain fragment Native protein fragment Cleavage site Signal sequence resemblance 
Intestinal extract 
1. INTRODUCTION 
It has been reported that some peptide 
fragments of hemoglobin can give rise to biological 
activities. Thus, the tetradecapeptide correspon- 
ding to residues 33-46 of the a-chain of porcine 
hemoglobin, has an in vitro ACTH-releasing ac- 
tivity [l], and neo-kyotorphin is an analgesic pep- 
tide corresponding to the C-terminal pentapeptide 
of human or bovine hemoglobin a-chains [2]. 
During attempts to improve the isolation pro- 
cedure [3] for the vasoactive intestinal polypeptide 
(VIP), the VIP fraction was obtained con- 
taminated with an additional polypeptide. We 
report here the characterization of this peptide. It 
is separated from VIP by one further step of ion- 
exchange chromatography. In spite of co- 
purification with VIP through 8 steps, the 
polypeptide was found not to be VIP-related. In- 
stead, the results show it to be a C-terminal frag- 
ment of hemoglobin P-chains. Data on the 
purification and amino acid sequence of this novel 
fragment, obtained as a side-fraction from the last 
purification step of porcine VIP, are given. The 
identification shows the presence of a special seg- 
ment in hemoglobin with some properties resembl- 
ing signal peptide cleavage sites. 
Peptide isolation 
2. MATERIALS AND METHODS 
2.1. Isolation of the polypeptide 
The material was obtained from the VIP- 
containing fraction after the first CM-cellulose 
chromatography (step 6, table 1) during VIP 
purification (cf. [3,4]). This fraction was 
chromatographed (step 7, table 1) on a second 
CM-cellulose column in 0.02 M Na-phosphate 
buffer (pH 6.4) with a gradient of NaCl 
(O-O.3 M). The fraction containing VIP, detected 
with the secretin bioassay [5], was further purified 
(step 8, table 1) by counter-current distribution [3]. 
Finally, the material containing both VIP and the 
additional polypeptide was chromatographed on a 
third CM-cellulose column in 0.1 M ammonium 
bicarbonate (step 9, table 1). 
2.2. Structural analysis 
Total compositions were determined with a 
Beckman 121 M amino acid analyzer after 
hydrolysis for 22 h at 110°C in evacuated tubes 
with 6 M HCl containing 0.5% phenol. The amino 
acid sequence was determined by the manual 
dimethylaminoazobenzene isothiocyanate method 
[6] utilizing by-products to assist identification [7] 
and by liquid-phase sequencer degradations in a 
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Table 1 
Isolation from intestinal extracts of the C-terminal 
fragment of hemoglobin D-chain 
Step 
no. 
Weight 
Upper part of porcine intestine 
(boiled, frozen and minced) 
Extraction with 0.5 M acetic acid: 
peptides adsorbed on alginic acid, 
eluted with 0.2 M HCI, and 
precipitated with NaQ 
Fractionation in 66070 ethanol; 
soluble materia1 adsorbed to 
alginic acid, eluted with 0.2 M 
HCI and precipitated with NaCl 
Exclusion chromatography on
Sephadex G-25 (fine) in 0.2 M 
acetic acid 
Extraction into methanol, soluble 
peptides precipitated with ether 
Exclusion chromatography on
Sephadex G-25 (fine) in 0.2 M 
acetic acid 
Ion-exchange chromatography on
CM-cellulose in 0.01 M 
Na-phosphate buffer (pH 8.0) 
Ion-exchange chromatography on
CM-cellulose in 0.02 M 
Na-phosphate buffer (pH 6.4) 
with a salt gradient (O-O.3 M 
NaCl) 
Counter-current distribution in 
0.1 M N&HCO3 : 1-butanol 
Ion-exchange chromatography on
CM-cellulose in 0.1 M NH~HCOJ 
36000 kg 
36 kg 
2150 g 
556 g 
82 g 
24 8 
7g 
1.5 g 
93.4 mg 
1.3 mg 
Beckman 890 D sequencer using a peptide pro- 
gram in the presence of glycine-precycled poly- 
brene [8]. The phenylthiohydantoin derivatives 
were identified by high-performance liquid 
chromatography [9] and thin-layer chromatog- 
raphy [lo]. 
3. RESULTS 
Table 2 shows the amino acid composition of the 
polypeptide. It lacks several amino acid residues: 
serine, threonine, methionine, isoleucine, tryp- 
tophan and cysteine. 
Fig.1 shows the complete amino acid sequence. 
This structure is identical to the C-terminal part 
(115-146) of the p-chain of porcine hemoglobin 
[ill. 
4. DISCUSSION 
Significantly, in size and some chemical proper- 
ties the new peptide is similar to the secretin group 
of peptides [121. The extensive co-purification bet- 
ween VIP and the new peptide is compatible with 
the structural results. The final separation in the 
third cation-ex~h~ge step (step 9, table 1) is also 
consistent with the structure determined and ap- 
pears to be explained by the less basic properties of 
the new peptide in relation to VIP (lower content 
of lysine and lack of C-terminal amide). 
The present detection of a hemoglobin fragment 
is one further illustration that such fragments exist 
in different biological extracts. Notably, an 
ACTH-releasing activity from an a-chain frag- 
ment has been detected [1], as well as an analgesic 
pentapeptide [2] also from a-chains, and now the 
C-terminal&chain fragment. Similarly, it has been 
shown that peptides with opioid activity, exor- 
phins, are formed after partial enzymatic digestion 
of gluten and casein [13,14]. Although no 
biological activity has been ascribed to the present 
hemoglobin fragment, its consistent presence may 
indicate it to have some role(s), and suggests a 
specific cleavage in the parent molecule. The 
cleavage site is preceded by a highly hydrophobic 
segment and produces an N-terminal alanine 
(fig.2). In both these respects, the preceding struc- 
ture resembles sites for signal peptide cleavages 
[15,16]. In fact, this region of hemoglobins-chains 
has close to 10 hydrophobic branched-chain 
residues without interruption by charged residues, 
and with positive charges at both ends (positions 
- 11 and + 2 in fig.2). Differential proteolysis to 
produce multiple forms of peptides has also been 
shown for molecules with established biological 
functions, like gastrin and cholecystokinin (CCK) 
[17], gastric inhibitory polypeptide (GIP) [18], 
adrenocorticotropic hormone (ACTH) [ 191 and 
insulin-like growth factor-2 (IGF-2) [20,21]. In ad- 
dition, specific fragments of proteins, demon- 
29 
Volume 170, number 1 FEBS LETTERS 
Table 2 
Amino acid compositions of the new hemoglobin fragment and its tryptic peptides isolated 
(Tz-T4) 
Amino 
acid 
Intact peptide 
Acid Sum of 
hydrolysis sequence 
determin- 
ation 
TZ T3 T4 
Asp 4.2 4 3.0 (3) 1.2 (1) - 
Glx 2.1 2 2.0 (2) _ - 
Pro 1.2 1 1.0 (1) _ - 
Gly 2.3 2 1.2 (1) 1.5 (1) - 
Ala 6.1 7 1.9 (2) 3.7 (4) - 
Val 3.1 4 1.1 (1) 2.4 (3) - 
Leu 2.4 2 1.1 (1) 1.1 (1) 
TYr 0.8 1 - - 1.0 (1) 
Phe 1.9 2 1.9 (2) _ 
LYS 2.1 2 1.0 (1) 1.2 (1) - 
His 2.6 3 0.9 (1) 0.9 (1) 1.0 (1) 
Arg 1.9 2 - _ - 
Total 32 15 12 2 
May 1984 
Values within parentheses represent he integers deduced from sequence determination 
1 5 10 15 
Ala-Arg-Arg-Leu-Gly-His-Asp-Phe-Asn-Pro-Asp-Val-Glx-Ala-Ala-Phe-Glx-Lys- 
7-7-1 -71111177/-11/1/1 
HTD HD HD HTD HTD HD HTD HTD HTD HTD HTD HTD HTD HTD HD HD HD HD 
12 12 8 7 6 6 4 
20 25 30 
I T2 I 
Val-Val-Ala-Gly-Val-Ala-Asn-Ala-Leu-Ala-His-Lys-Tyr-His 
-7~77-,--7-7-/-I-/II--I-7 
HD HD HD HD HD H H H H H A H H A 
4 4 4 11 
a T3 II- T4 --I 
Fig. 1. Results of amino acid sequence analysis of the new peptide. Liquid-phase sequencer-assisted analysis is shown 
by -. Residue identification: high-performance liquid chromatography, H; thin-layer chromatography, T. Figures 
below the letters denote nmol stable residues recovered from degradation of 20 nmol peptide. Repetitive yield calculated 
on alanine 1-21 is 95%. In addition, results of manual sequence analysis of the intact peptide (9 nmol) with the 
dimethylaminoazobenzene isothiocyanate method are shown by D and identifications from total compositions by A. 
Tryptic fragments Tz-T4, purified by reverse-phase high-performance liquid chromatography, are also shown. 
30 
Volume 170, number 1 FEBS LETTERS May 1984 
-15 -10 -5 -1 
& 
1 5 
Pro-Glu-Asn-Phe-Arg-Leu-Leu-Gly-Asn-Val-Ile-Val-Val-Val-Leu-Ala-Arg-Arg-Leu-Gly- 
10 15 20 25 
His-Asp-Phe-Asn-Pro-Asp-Val-Gln-Ala-Ala-Phe-Gln-Lys-Val-Val-Ala-Gly-Val-Ala-Asn- 
30 
Ala-Leu-Ala-His-Lys-Tyr-His 
Fig.2. The amino acid sequence of the C-terminal part of hemoglobinfl-chains, demonstrating the structure around the 
site where cleavage (arrow) liberates the isolated peptide (underlined). 
strating cleavages in the parent molecules, have 
been described for several large polypeptide chains 
including fibrinogen [22] and &-microglobulin 
[23]. These examples indicate that cleavages in pro- 
teins may be specific and more frequent than often 
assumed, raising the question as to whether the 
cleavage products may have biological functions. 
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